Responses
Clinical/translational cancer immunotherapy
Original research
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas
Compose a Response to This Article
Other responses
No responses have been published for this article.